Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Lyra Health Partners with ParetoHealth for SMB Mental Care
ParetoHealth announced that Lyra Health, a top provider of mental health services for workplaces, will now be available to members via the ParetoHealth Savings Engine. This new partnership will help more people get access to quality mental health care, reaching over 3,500 employers and 1.2 million people. This means smaller and medium-sized businesses can now offer mental health benefits that were mostly available to large companies before.
Prime Therapeutics and Sempre Health Launch Affordable Care Model
Prime Therapeutics LLC (Prime), a pharmacy solutions organization focused on delivering savings, simplicity, and support, is expanding access to behavior-based medication pricing through a nationwide engagement with Sempre Health (Sempre). This strategic initiative strengthens Prime’s commitment to innovation in prescription affordability and adherence, offering clients new ways to help their commercial members save and stay on therapy.
ArkBio Launches Phase II Trial of AK0610 RSV Antibody
Shanghai Ark Biopharmaceutical Co., Ltd., also referred to as ArkBio, has announced the start of a Phase II clinical trial for AK0610, a fully human monoclonal antibody aimed at preventing respiratory syncytial virus (RSV) infection in babies. This development is a significant milestone for ArkBio’s research focused on RSV and adds to its growing range of innovative treatments for the virus. Leveraging previous clinical experience, the company is working to offer a long-lasting preventive solution to tackle this widespread and serious infection.
Piramal Pharma Partners with IntoCell to Boost Bioconjugates
Piramal Pharma Solutions, a global leader in contract development and manufacturing and part of Piramal Pharma Ltd., has entered into a strategic partnership with IntoCell Inc., a Korean biotech company recognized for its innovative antibody-drug conjugate linker and payload technologies. The agreement is non-exclusive and non-binding, allowing IntoCell to explore licensing opportunities for its proprietary drug-linker platforms with Piramal’s clients. In return, Piramal will offer full contract research, development, and manufacturing services for bioconjugates, including antibody-drug conjugates (ADCs), to IntoCell and its clients.
Conexiant Launches MDspire AI Platform for Medical Professionals
Conexiant has introduced MDspire, a new AI-powered platform aimed at changing the way doctors, researchers, and healthcare professionals access and interact with clinical knowledge. The platform is designed to tackle the problems of content fatigue and information overload by gathering trustworthy medical information and turning it into useful insights. MDspire provides short, easy-to-read pieces of content in a feed-style format, sourced from top medical societies, peer-reviewed journals, hospital systems, and exclusive research. This ensures healthcare professionals can get the information they need in a quick and clear way.
To share your insights, please write to us at tony@intentamplify.com
